Literature DB >> 18070236

Reduction of interstitial cells of Cajal (ICC) associated with neuronal nitric oxide synthase (n-NOS) in patients with achalasia.

Ines Gockel1, Juergen R E Bohl, Volker F Eckardt, Theodor Junginger.   

Abstract

BACKGROUND: The etiology of achalasia is still unknown. The current theories of chronic inflammation leading to autoimmune response with destruction and loss of the inhibitory myenteric ganglion cells enlighten its pathogenesis in a limited way only. Interstitial cells of Cajal (ICC) have been shown to be involved in nitrergic neurotransmission of the lower esophageal sphincter (LES). AIM: To investigate the significance of ICC and neuronal nitric oxide synthase (n-NOS) in esophageal wall tissue of patients undergoing surgery for achalasia.
METHODS: In 53 patients with a median age of 45 (6-78) yr undergoing surgery for achalasia, the immunoreactivity of ICC (CD117/c-kit) and n-NOS was assessed. In 42 patients, biopsies were taken from the LES high-pressure zone during Heller myotomy, whereas in 11 patients with end-stage achalasia and a decompensated megaesophagus, the complete esophagus was resected. A semiquantitative analysis was carried out and ICC and n-NOS impairments were classified into four grades. Staining intensity was correlated with preoperative clinical, radiologic, and manometric findings and with long-term postoperative Eckardt score.
RESULTS: Grade III/IV ICC reduction (severe reduction to complete loss) was seen in 59.5% of all biopsy specimens of the LES high-pressure zone. Patients with grade III/IV ICC reduction had a significantly longer duration of achalasia symptoms (3 [0-43] yr) than patients with minor to marked (grade I/II) impairment (1 [0-16] yr, P= 0.028). A majority (72.5%) of tissue samples revealed severe reduction to complete loss of n-NOS immunoreactivity. The preoperative Eckardt score was statistically significantly different between patients with grade I/II and those with grade III/IV n-NOS reductions (P= 0.031). CD117 (c-kit) positivity was statistically significantly correlated with n-NOS staining intensity (correlation coefficient r= 0.781, P < 0.0001).
CONCLUSION: The present results suggest that in the pathogenesis of achalasia, especially in the development of the LES high-pressure zone, depletion of ICC networks and potential changes in the electrical activity of smooth muscle cells may play a crucial role. The reduction in CD117-positive ICC in a few patients also seemed to be of relevance, even if the cells of Auerbach's plexus were unscathed. The associated reduced NOS release might underlie the profound ICC impairment and could possibly be responsible for the lack of LES relaxation, because of missing inhibitory neurotransmission. It is unclear, however, whether the ICC loss is primarily caused by the accelerated attrition of mature cells or their impaired regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070236     DOI: 10.1111/j.1572-0241.2007.01667.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

Review 1.  Neuronal Control of Esophageal Peristalsis and Its Role in Esophageal Disease.

Authors:  K Nikaki; A Sawada; A Ustaoglu; D Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2019-11-23

2.  Possible new endoscopic finding in patients with achalasia: "Gingko leaf sign".

Authors:  Yoshimasa Hoshikawa; Shintaro Hoshino; Noriyuki Kawami; Tomohide Tanabe; Yuriko Hanada; Nana Takenouchi; Osamu Goto; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  Esophagus       Date:  2019-06-21       Impact factor: 4.230

3.  Distal contraction latency: a measure of propagation velocity optimized for esophageal pressure topography studies.

Authors:  Sabine Roman; Zhiyue Lin; John E Pandolfino; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2010-10-26       Impact factor: 10.864

4.  [Technical aspects of laparoscopic Heller myotomy for achalasia].

Authors:  I Gockel; S Timm; T J Musholt; A Rink; H Lang
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

Review 5.  Peroral endoscopic myotomy: an evolving treatment for achalasia.

Authors:  Robert Bechara; Haruo Ikeda; Haruhiro Inoue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-02       Impact factor: 46.802

Review 6.  Recent advancement of therapeutic endoscopy in the esophageal benign diseases.

Authors:  Robert Bechara; Haruhiro Inoue
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

7.  Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children.

Authors:  Ricardo A Arbizu; Leonel Rodriguez
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

8.  Tailoring Therapy for Achalasia.

Authors:  Joel E Richter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-05

9.  Partial recovery of peristalsis after myotomy for achalasia: more the rule than the exception.

Authors:  Sabine Roman; Peter J Kahrilas; François Mion; Thomas B Nealis; Nathaniel J Soper; Gilles Poncet; Frédéric Nicodème; Eric Hungness; John E Pandolfino
Journal:  JAMA Surg       Date:  2013-02       Impact factor: 14.766

Review 10.  The chronic gastrointestinal manifestations of Chagas disease.

Authors:  Nilce Mitiko Matsuda; Steven M Miller; Paulo R Barbosa Evora
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.